# BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

> **NCT06673459** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 430 (estimated)

## Conditions studied

- T-Cell Lymphocytic Leukemia
- ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Total Body Irradiation
- Chemotherapy

## Interventions

- **BIOLOGICAL:** TBICy
- **BIOLOGICAL:** BuCy

## Key facts

- **NCT ID:** NCT06673459
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2029-11-30
- **Final completion:** 2029-11-30
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2024-11-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06673459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06673459, "BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06673459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*